Latest Commercialisation News

Page 63 of 116
Strategic Elements Ltd has marked significant progress in its Energy Ink™ prototype trials and underground mining technology, maintaining a robust financial footing with $4.21 million cash and no debt.
Sophie Babbage
Sophie Babbage
31 July 2025
Percheron Therapeutics has licensed HMBD-002, a promising immuno-oncology candidate, completed FDA IND transfer, and plans to launch phase II trials in 2026. The company also reported a solid cash position and issued loyalty options to shareholders.
Ada Torres
Ada Torres
31 July 2025
First Graphene Limited reports over A$1.2 million in annual income, driven by new commercial orders and breakthrough graphene applications in mining safety boots and cement additives.
Maxwell Dee
Maxwell Dee
31 July 2025
Bio-Gene Technology Limited has secured $2.45 million to fund critical safety studies and scale-up production of its novel insecticides Flavocide and Qcide, positioning the company for upcoming regulatory approvals and commercial partnerships.
Ada Torres
Ada Torres
31 July 2025
Firebird Metals has made significant strides in its lithium manganese iron phosphate (LMFP) battery strategy, unveiling a new lab-scale cathode production facility and securing key patents. The company also demonstrated major energy savings in kiln trials, positioning itself strongly in the evolving battery materials market.
Maxwell Dee
Maxwell Dee
30 July 2025
Zelira Therapeutics reports promising diabetic neuropathy study results with ZLT-L-007 surpassing Lyrica, while converting $3.25 million in notes to equity to bolster HOPE® 1 clinical development.
Ada Torres
Ada Torres
30 July 2025
Aeris Environmental reported a robust 62% revenue increase in the June 2025 quarter, driven by new international contracts and expanding adoption of its Syncromesh IoT platform.
Sophie Babbage
Sophie Babbage
30 July 2025
Orbital Corporation reports a $0.5 million operating cash outflow for Q2 2025, while progressing development of a larger UAV engine now entering customer flight trials.
Victor Sage
Victor Sage
30 July 2025
Cambium Bio has raised A$2.12 million through a fully subscribed placement led by Taiwanese institutional investor Da Jyun Capital, supporting the initiation of pivotal Phase 3 trials for its lead ophthalmology candidate.
Ada Torres
Ada Torres
30 July 2025
Memphasys Limited has submitted its Felix™ sperm separation system for CE Mark approval, targeting Europe’s $5 billion IVF market, while expanding direct sales in Japan and validating its RoXsta™ oxidative stress diagnostic platform.
Ada Torres
Ada Torres
30 July 2025
Altech Batteries confirms the safety and durability of its CERENERGY® sodium-nickel-chloride battery technology through rigorous testing, while its Silumina Anodes™ pilot plant in Germany achieves a 50% capacity increase. An independent DNV study endorses the technology’s promising future.
Victor Sage
Victor Sage
30 July 2025
Codeifai Limited has raised $2.35 million through a share placement to fund key acquisitions and expand its footprint in quantum computing and AI. The move signals a strategic push towards U.S. market engagement and commercialisation of cutting-edge technology.
Sophie Babbage
Sophie Babbage
30 July 2025